Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Prevention of recurrent Clostridioides difficile infection by fecal microbiota, live-jslm (REBYOTA®) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trial.
Journal: Therapeutic advances in gastroenterology
Published: October 10, 2025
Safety and effectiveness of fecal microbiota, live-jslm (REBYOTA®) administered by colonoscopy for prevention of recurrent Clostridioides difficile infection: 8-week results from CDI-SCOPE, a single-arm, phase IIIb trial.
Journal: Therapeutic advances in gastroenterology
Published: March 31, 2025
Colorectal cancer development and advances in screening.
Journal: Clinical interventions in aging
Published: August 04, 2016
Transcription factor zinc finger and BTB domain 1 is essential for lymphocyte development.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 04, 2012
Showing 1-4 of 4
Last Updated: 09/26/2026